Sam (1815 – after 1827) was a British Thoroughbred racehorse and sire. In a career that lasted from April 1818 to May 1819 he ran nine times and won three races. In May 1818 he defeated fifteen opponents to record his most important win in the Epsom Derby. His only other wins came in a walkover and a match race. After running without success as a four-year-old, Sam was retired to stud but made no impact as a sire of winners.
Sam was described as a "low, lengthy and plain sort of horse, with a sour countenance, and a delicate constitution," sired by the Doncaster Cup winner Scud out of the mare Hyale. Hyale produced several other winners and was a half-sister to Goosander, a highly successful broodmare who produced the Epsom Oaks winner Shoveler and the Derby winner Sailor. Sam was bred by his owner, Thomas Thornhill at his stud at Riddlesworth, Norfolk, and trained by Thornhill's father-in-law, Mr Perren.
Sam was named after his regular jockey Sam Chifney, Jr. Chifney was one of the outstanding jockeys of his era, and one of the first to hold horses up in the early stages of a race before finishing strongly: he became famous for this tactic which became known as the "Chifney Rush". He eventually became the joint-trainer of the colt that bore his name.
The horse (Equus ferus caballus) is one of two extant subspecies of Equus ferus. It is an odd-toed ungulate mammal belonging to the taxonomic family Equidae. The horse has evolved over the past 45 to 55 million years from a small multi-toed creature, Hyracotherium, into the large, single-toed animal of today. Humans began to domesticate horses around 4000 BC, and their domestication is believed to have been widespread by 3000 BC. Horses in the subspecies caballus are domesticated, although some domesticated populations live in the wild as feral horses. These feral populations are not true wild horses, as this term is used to describe horses that have never been domesticated, such as the endangered Przewalski's horse, a separate subspecies, and the only remaining true wild horse. There is an extensive, specialized vocabulary used to describe equine-related concepts, covering everything from anatomy to life stages, size, colors, markings, breeds, locomotion, and behavior.
Horses' anatomy enables them to make use of speed to escape predators and they have a well-developed sense of balance and a strong fight-or-flight response. Related to this need to flee from predators in the wild is an unusual trait: horses are able to sleep both standing up and lying down. Female horses, called mares, carry their young for approximately 11 months, and a young horse, called a foal, can stand and run shortly following birth. Most domesticated horses begin training under saddle or in harness between the ages of two and four. They reach full adult development by age five, and have an average lifespan of between 25 and 30 years.
A horse is a hoofed mammal of the species Equus ferus caballus.
Horse or Horses may also refer to:
Horses are an important motif in Chinese mythology. There are many myths about the horse or horses, or horse-like beings, including the pony. Chinese mythology refers to those myths found in the historical geographic area of China. This includes myths in Chinese and other languages, as transmitted by Han Chinese as well as other ethnic groups (of which fifty-six are officially recognized by the current administration of China, according to Lihui Yang, 2005:4). There are various motifs of horses in Chinese mythology. In some cases the focus is on a horse or horses as the protagonist of the action, in other cases they appear in a supporting role, sometimes as the locomotive power propelling a chariot and its occupant(s). According to a cyclical Chinese calendar system, the time period of 31 January 2014 - 18 February 2015 falls under the category of the (yang) Wood Horse.
In the study of historical Chinese culture, many of the stories that have been told regarding characters and events which have been written or told of the distant past have a double tradition: one which tradition which presents a more historicized and one which presents a more mythological version (Yang 2005:12-13). This is also true of some accounts related to mythological horses in China.
Sam (Serbian Cyrillic: Сам) is an album by Škabo, a member of the Belgrade hip hop collective Beogradski sindikat, released in 2003 by One Records. It contains the following fifteen tracks:
1. Последња 2 минута/Poslednja 2 minuta
2. Курцони/Kurtzoni
3. Дрина рурал експиријенс/Drina rural ekspirijens
4. Сети се деведестих/Seti se devedesetih
5. Слатке торе потице/Slatke tore potice
6. Клуб је врућ/Klub je vruć
7. Саопштење (са Ђолетом)/Saopstenje (feat. Đolođolo)
8. Последњи удар/Poslednji udar
9. Сувише млад за умирање (са Јојцем)/Suviše mlad za umiranje (feat. Jojac)
10. Зараза/Zaraza
11. Заточеник/Zatočenik
12. Маестро 2/Maestro 2
13. Курве/Kurve
14. Шта ћу вам ја?/Šta ću vam ja?
15. Сам/Sam
SAM 26000 was the first of two Boeing VC-137C United States Air Force aircraft specifically configured and maintained for use by the President of the United States. It used the callsign Air Force One when the President was on board, SAM 26000 otherwise.
A VC-137C with Air Force serial number 62-6000, SAM 26000 was a customized Boeing 707. It entered service in 1962 during the administration of John F. Kennedy and was replaced in Presidential service in 1972 but kept as a backup. The aircraft was finally retired in 1998 and is now on display at the National Museum of the United States Air Force.
The aircraft was built at Boeing's Renton plant at a cost of $8 million. Raymond Loewy, working with First Lady Jacqueline Kennedy, designed the blue and white color scheme featuring the presidential seal that is still used today. The plane served as the primary means of transportation for three presidents: Kennedy, Lyndon B. Johnson, and Richard Nixon during his first term. In 1972, during the Nixon administration, the plane was replaced by another 707, SAM 27000, although SAM 26000 was kept as a back-up plane until 1998.
Cerlapirdine (USAN; SAM-531, WAY-262,531, PF-05212365) is a drug which is under development by Wyeth/Pfizer for the treatment of cognitive disorders associated with Alzheimer's disease and schizophrenia. As of 2011, it is in phase II clinical trials, and has demonstrated a trend toward efficacy along with a good side effect profile and no incidence of serious adverse events. It exerts its effects by acting as a selective 5-HT6 receptor antagonist.